In this study, using a multi-etiological, multi-stage real-world cohort of patients with liver cirrhosis, we aimed to investigate the diagnostic value of soluble PDGFRβ for HCC, and to compare, develop, and validate novel serological diagnostic HCC scoring-tools. Here, PDGFRB is linked to hepatocellular carcinoma.